long intergenic non-protein coding RNA 2358Genealiases: []
Q-omics provides the consensus-scored LINC02358 profile across patient tissues and cancer cell-line models. LINC02358 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, LINC02358 is differentially expressed in 1, with the highest sampling consensus in KICH. Additionally, LINC02358 RNA expression shows 7,489 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight UCS, KICH, and COAD as cancer lineages where LINC02358 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02358 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02358 survival associations across molecular data types. LINC02358 RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02358 RNA expression–survival associations across cancer types. High LINC02358 expression shows unfavorable associations in UCS, UVM, UCEC, SKCM and ESCA, but favorable associations in STAD. The UCS Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCS as the clearest survival context for LINC02358 RNA expression.
This table summarizes LINC02358 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02358. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02358 shows higher tumor expression in KICH. The KICH box plot shows higher LINC02358 RNA expression in tumor versus normal tissue (log2 FC = +0.077, t-test p = .019).
This table shows molecular features associated with LINC02358 in patient tissues and cancer cell lines. In patient samples, LINC02358 shows the broadest associations at the RNA and protein expression levels, with COAD recurring as the lineage with the largest associated feature set.
